Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction
نویسندگان
چکیده
منابع مشابه
Impact of Patient-Reported Outcomes on Clinical Practice
This working document is part of a series developed by the NIH Health Care Systems Research Collaboratory Patient-Reported Outcomes (PRO) Core to provide and develop strategies, tools, and resources related to the measurement, collection, and analysis of patient-generated health information, including patient-reported outcomes data. This work was supported by a cooperative agreement (U54 AT0077...
متن کاملAssessing Patient-Reported Outcomes Following Orthognathic Surgery and Osseous Genioplasty.
Primary outcomes for orthognathic surgery and genioplasty patients include satisfaction with appearance, improved motor function, and enhanced quality of life. The goal of this study was to assess outcomes among patients undergoing these procedures, and to highlight the potential use of FACE-Q instrument for use in patients with dentofacial deformities. A total of 56 patients presenting for ort...
متن کاملPatient-Reported Outcomes, Patient-Reported Information
Internet communication is developing. Social networking sites enable patients to publish and receive communications very easily. Many stakeholders, including patients, are using these media to find new ways to make sense of diseases, to find and discuss treatments, and to give support to patients and their caregivers. We argue for a new definition of patient-reported information (PRI), which di...
متن کاملImpact of Measuring Patient-Reported Outcomes in Dermatology Drug Development.
Although some symptoms of dermatologic diseases, such as pruritus and pain, can be subjectively assessed only by patients, the most commonly used endpoints in dermatology drug research traditionally have been clinician-reported outcomes. Research has found that patient-reported outcomes (PROs) were included in only one-quarter of 125 trials conducted between 1994 and 2001. Our objective was to ...
متن کاملImpact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis
OBJECTIVE Patient-reported outcomes (PROs) provide an opportunity to collect important information relating to patient well-being, which is often difficult for physicians to measure (e.g., quality of life, pain, fatigue, and sleep). Here we evaluate the effects of certolizumab pegol (CZP) on PROs during the 24-week, double-blind phase of the RAPID axial spondyloarthritis (SpA) trial, a phase 3 ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: RMD Open
سال: 2021
ISSN: 2056-5933
DOI: 10.1136/rmdopen-2021-001566